We prospectively studied the reconstitution of lymphocyte subpopulations in a group of 22 children, who survived disease-free at least 6 months after allogeneic BMT for a haematological malignancy. Absolute counts of total lymphocytes, B lymphocytes, T lymphocytes, and CD4 ϩ helper T lymphocytes reached the 5th percentile (p 5 ) of age-matched reference values within 6 months after BMT in 15, 17, 7 and 2 patients, respectively. In particular, CD4 ϩ helper T lymphocyte reconstitution was very slow. Unexpectedly, CMV reactivation had a profound positive influence upon the number of CD4 ϩ helper T lymphocytes in the children. In five patients, absolute B lymphocyte counts above the 95th percentile were reached from 6 months after BMT onwards, mimicking normal ontogeny. Unlike normal ontogeny, the percentages of helper T lymphocytes expressing the 'naive' CD45RA isoform were low and those expressing the 'memory' CD45RO isoform were high in the first 3 months after BMT, as described before. Thereafter, the CD45RA:CD45RO ratio slowly normalised. Also, CD7 expression was absent on up to 90% of T lymphocytes in the first months after BMT, and on a steadily decreasing percentage thereafter, as recently described in adults. However, the absolute counts of CD45RO ϩ
disorders. [1] [2] [3] Unfortunately, infectious morbidity and mortality resulting from the period of immunodeficiency early post transplant are an important side-effect of BMT.
Studies on immune reconstitution after allogeneic BMT have been performed extensively in adults. [4] [5] [6] [7] [8] [9] The innate immune system (phagocytes) fully recovers in the first weeks to months after BMT, but complete functional reconstitution of the adaptive immune system (B and T lymphocytes) takes much longer. Therefore, infectious complications continue to be a problem for many months after BMT. 3, 10 In particular, the reconstitution of CD4 ϩ helper T lymphocytes is very slow in adults. This could be related to decreasing thymic function with age. Presumably, reconstitution of the T cell compartment shortly after BMT is mainly provided by a peripheral expansion of donor T lymphocytes present in the graft, and not by donor stem cells undergoing the normal developmental pathways in the bone marrow and thymus. 4, 11 This fits in with the observation that CD45RO
ϩ 'memory' CD4 ϩ helper T lymphocytes are present at a high relative frequency in peripheral blood after BMT in adults. 12 Results of studies on T cell regeneration after courses of intensive chemotherapy indicate that the thymus-dependent repopulation of 'naive' CD4 + helper T lymphocytes occurs with a shorter delay in children than in adults. 13, 14 In children, however, only limited data on immune reconstitution after BMT are available. 15, 16 Therefore, we investigated the T and B cell lineages in peripheral blood by immunophenotyping in 22 children longitudinally after allogeneic BMT for a haematological malignancy. Because of the low total lymphocyte counts shortly after BMT, changes in lymphocyte subpopulation size are better represented by their absolute counts than by their relative frequencies. 17 Therefore, we studied the dynamics of reconstitution by calculating the absolute counts of the different lymphocyte subpopulations. These results were related to age-matched reference values for healthy children from the literature if available, 17 and otherwise to the values found in age-matched BMT donors.
Materials and methods

Patients
Between October 1990 and April 1994, absolute counts and relative frequencies of peripheral blood lymphocyte subpopulations were determined prospectively in 22 of 34 consecutive paediatric patients who underwent allogeneic BMT for a haematological malignancy at the Department of Paediatrics of the Leiden University Medical Centre. These 22 children survived disease-free for at least 6 months post transplant and had at least three post-transplant samples analysed during up to 18 months of follow-up. Clinical data concerning these children are summarised in Table 1 .
Surveillance for herpesvirus reactivation
At weekly intervals after BMT, throat swabs were cultured for herpes simplex virus (HSV), and throat swabs and urine samples were cultured for CMV. White blood cells were investigated once weekly from 3 weeks after BMT onwards for the presence of the nuclear CMV-related antigen pp65 in seropositive recipients. 19 Serology for HSV, VZV, CMV and EBV was performed before BMT, and on indication after BMT (results in Table 1 ). Reactivation was defined as isolation of the virus from the throat (HSV), the throat and/or urine (CMV) or antigen detection in the blood (CMV). Disease was defined as reactivation combined with signs of organ involvement, eg hepatitis, pneumonitis (CMV), mucositis (HSV), skin lesions (VZV), and lymphoproliferation (EBV). Eleven patients were at risk for CMVrelated problems (positive serology pre-BMT in donor and/or recipient), 13 for HSV-, 17 for EBV-, and 18 for VZV-related problems (Table 1) . None of the patients received viral prophylaxis.
Immunostaining of membrane antigens
Leukocyte counting was performed on EDTA-blood using a Sysmex F800 haematological counter (Toa Medical Electronics, Kobe, Japan), and leukocytes were differentiated on blood smears stained with May-Grünwald-Giemsa. PBMC were isolated by Ficoll density gradient centrifugation. Interface cells were resuspended in lysis buffer to remove the erythrocytes, followed by incubation at 37°C to remove immunoglobulins bound non-specifically to the cell membrane.
The various cell populations present among PBMC were identified according to the surface expression of lineagespecific antigens after two-colour immunostaining (Table  2) . CD3 ϩ /CD8 ϩ suppressor/cytotoxic T lymphocytes were not measured directly in the oldest samples (25%), but estimated by the investigation of total CD8 ϩ lymphocytes. In short, 50 l of the cell suspension containing 0.1-1.0 ϫ 10 6 PBMC was incubated in the dark for 30 min at room temperature with 25 l of fluorochrome-conjugated MoAb. The cells were washed once with PBS containing 1% (w/v) BSA. All media contained NaN 3 to prevent antibody internalisation.
Immunostaining patterns were analysed by flow cytometry (FACScan, Becton Dickinson, San Jose, CA, USA), and data were analysed using the Cellquest software package. A gate was set around the lymphocyte population on the basis of forward and side scatter characteristics and staining patterns of CD45 and CD14 MoAb (CD45 ϩ /CD14 Ϫ cells).
Recovery of lymphocyte subpopulations
Normalisation of the absolute counts of a given lymphocyte (sub)population in the peripheral blood of a patient was defined as reaching the 5th percentile (p 5 ) of age-matched reference values published in the literature. 17 When agematched reference values were not available, a comparison was made with data from age-matched BMT donors analysed between September 1992 and April 1997 (1-5 years of age, n ϭ 29; 5-10 years of age, n ϭ 30; 10-18 years of age, n ϭ 45).
CMV-specific lymphocyte activation
Child No. 21 suffered from CMV-reactivation with pp65 detectable in white blood cells and CMV cultured from urine from 1 to 4.5 months after BMT. CMV-specific T cell responses were measured at day ϩ80, day ϩ220, and day ϩ264 post transplant. Briefly, PBMC were stimulated with CMV (AD169) infected HEL cells, and uninfected HEL cells as control. After 6 h of stimulation, cells were analysed by flow cytometry for surface expression of the activation marker CD69 and the intracellular presence of IFN␥ according to Waldrop et al. 20 After 5 days of stimulation 3 H-thymidine was added to the cultures and incorporation during the final 16 h of incubation was measured.
Statistics
The p 5 recovery data were analysed with life table techniques, taking into account that only the time interval was known in which the recovery took place, ie the data were so-called interval-censored. 21 The time-intervals are shown in Table 1 : eg for patient No. 1, the recovery of helper T lymphocytes took place somewhere between day 28 and day 77, whereas for patient No. 2 reconstitution had not yet occurred at the last day of follow-up (day 167); this patient is censored. The curves for the cumulative risk on reconstitution were estimated for the total group, as well as for patients with and without CMV-reactivation (CMV ϩ and CMV Ϫ ), with an HLA-identical (HLA-id) and with a matched unrelated donor (MUD), and with and without T cell depletion (TCD) (TCD ϩ and TCD Ϫ ), separately. The comparison of the groups of CMV ϩ and CMV Ϫ patients, the groups with an HLA-id and a MUD donor, and the groups of TCD ϩ and TCD Ϫ transplants, is expressed as the relative risk (RR) of reaching the p 5 of age-matched reference values, and its 95% confidence interval. The analysis of interval censored data is not available in standard statistical packages. It was done using the GAUSS package and the Turnbull algorithm. 
Results
Clinical course (see also Table 1)
Six children developed CMV-reactivation within 2 months post transplant (5 HLA-id, 1 MUD), none had overt disease. Two children suffered from HSV-stomatitis, and one child developed generalised VZV-related skin eruptions; they were treated successfully with i.v. acyclovir. There were no EBV-related problems in the study group. Grade I acute GVHD was observed in one child (HLA-id), limited chronic GVHD developed in another child (MUD). Due to the limited occurrence of complications in these 22 children, the influence of the development of GVHD or herpesvirus-reactivation on lymphocyte reconstitution after BMT could not be analysed, except for CMV-reactivation (see below). ϩ helper T lymphocytes remained very low up to 18 months after BMT, despite the fact that all BMT recipients were children. They reached the p 5 of age-matched reference values within 3 months after BMT in only one patient (5%; HLA-id), and in only one more patient (5%; HLA-id) between 3 and 6 months after BMT. There was no significant difference in the rate of recovery of the main lymphocyte subpopulations between HLA-id and MUD transplants, or between TCD ϩ and TCD Ϫ transplants (Table 3 ). The one haplo-id/TCD ϩ transplanted patient did not show any recovery of the main lymphocyte subpopulations in the first 6 months after BMT.
Recovery of the main lymphocyte populations (see also
The influence of CMV-reactivation
Two patients (Nos 1 and 3; both HLA-id) showed an initial peak in their total lymphocyte counts early post transplant (7.3 ϫ 10 9 /l at ϩ42 days and 5.3 ϫ 10 9 /l at ϩ50 days, respectively); both were excreting CMV in their urine, and pp65 was detectable in their blood leukocytes at that time. They also showed an initial peak in their T lymphocyte counts Although there was a trend towards faster quantitative T lymphocyte recovery among the children with CMV-reactivation, this was not significantly different from the recovery of T lymphocytes in children without CMV-reactivation: relative risk CMV ϩ vs CMV Ϫ 2.36, 95% confidence interval 0.82-6.70. Estimated suppressor/cytotoxic T lymphocyte recovery (assessed as total T lymphocyte minus CD4 ϩ helper T lymphocyte counts) was faster among the children with CMV-reactivation: relative risk CMV ϩ vs CMV Ϫ 3.48, 95% confidence interval 1.12-10.6 (Table 3) . Unexpectedly, CD4 ϩ helper T lymphocyte recovery was significantly faster in children with CMV-reactivation: relative risk 12, 95% confidence interval 2.1-90 (Table 3 and Figure 1) . To assess whether the faster reconstitution of T lymphocytes was related to CMV-specific activation, PBMC available from child No. 21 at different time points after BMT were stimulated in vitro with CMV. A clear, but low, CMV-specific proliferative response was only observed at ϩ220 days post transplant. Also, the combined analysis of cell surface expression of CD69 and intracellular expression of IFN␥ by flow cytometry indicates only a marginal, if relevant, presence of CMV-specific T lymphocytes at any of these time points (Table 4 ). There was no influence of CMV-reactivation on B lymphocyte recovery (relative risk 1.01, 95% confidence interval 0.31-2.57) ( Table 3) .
CD45RA and CD45RO expression on helper T lymphocytes
Early post transplant, the percentage of helper T lymphocytes expressing the 'naive' CD45RA isoform was low, showing an increase (Figure 2a ) from a median of 20% in the first blood samples at 1-2 months (Figure 3a) to a median of 50-60% at Ͼ3 months after BMT. BMT donors (see Material and methods) showed a median percentage of helper T lymphocytes expressing the 'naive' CD45RA isoform of 75%, 66%, and 64% at 1-5 years, 5-10 years, and 10-18 years of age, respectively. The percentage of helper T lymphocytes expressing the 'memory' CD45RO isoform was high, showing a decrease (Figure 2b ) from a median of around 90% (TCD Ϫ median 84%, TCD ϩ median 92%) in the first blood samples at 1-2 months (Figure 3b ) to a median of 40-30% at Ͼ3 months after BMT. BMT donors showed a median percentage of helper T lymphocytes expressing the 'memory' CD45RO isoform of 18%, 32%, and 34% at 1-5 years, 5-10 years, and 10-18 years of age, respectively. This pattern of expression of the CD45
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Predominance of CD7 Ϫ T lymphocytes early post transplant
In the first blood samples at 1 month after BMT, CD7 was not expressed on a median of around 70% of T lymphocytes (HLA-id/TCD Ϫ median 62%, MUD/TCD ϩ 1 sample 77%) (Figure 3c ). The percentage of CD7 Ϫ cells within the T lymphocyte population decreased quickly after BMT (Figure 2c ) to a median of 40% at 2-3 months, 20% at 6 months (Figure 3d) , and 10% in the second year post transplant. BMT donors showed a median percentage of CD7 Ϫ cells within the T lymphocyte population of 5%, 7%, and 7% at 1-5 years, 5-10 years, and 10-18 years of age, respectively. At 1 month after BMT the median absolute count of CD7 Ϫ /CD3 ϩ T lymphocytes was 0.5 ϫ 10 9 /l. Thereafter it did not change significantly during the remaining follow-up period from 2 to 18 months after BMT (median 0.1-0.2 ϫ 10 9 /l). The median absolute count of CD7 Ϫ /CD3 ϩ T lymphocytes in BMT donors was 0.1 ϫ 10 9 /l in all age groups. Six patients showed high absolute counts of CD7 Ϫ /CD3 ϩ T lymphocytes in the first 3 months after BMT (1.0-2.5 ϫ 10 9 /l). Four of these patients suffered from CMV-reactivation. The median absolute count of CD7 ϩ /CD3 ϩ T lymphocytes slowly increased from 0.4 ϫ 10 9 /l at 1 month after BMT to 1.6 ϫ 10 9 /l at 12-18 months after BMT. CD7 expression on CD4 ϩ helper T lymphocytes and on CD8 ϩ cells followed a similar pattern (data not shown). 
CD5 ϩ B-lymphocytes
Although the median percentage of CD5 ϩ cells within the B-lymphocyte population decreased from 65% (median) at 1-2 months after BMT (HLA-id median 65%, MUD/TCD ϩ 2 samples 46% and 48%) to 42% (median) at у1 year after BMT, the absolute counts of CD5 ϩ /CD20 ϩ B lymphocytes remained stable during the entire follow-up period (median 0.3 ϫ 10 9 /l at 1-2 months after BMT to 0.4 ϫ 10 9 /l at у1 year after BMT). 
Discussion
We prospectively analysed the reconstitution of lymphocyte subpopulations after allogeneic BMT in a group of 22 children transplanted for a haematological malignancy. The recovery, measured in terms of crossing the p 5 of agematched reference values, 17 was slow. In one third of the children, the absolute lymphocyte counts had still not reached the p 5 of age-matched reference values 6 months after BMT. In addition, B and T lymphocytes showed a different pattern of recovery.
The absolute counts of B lymphocytes recovered relatively fast after BMT, reaching the p 5 within 6 months post transplant in 77% of the children. A quarter of the children, all transplanted with an HLA-id donor, reached values above the p 95 , resembling normal ontogeny during the first year of life, as described before.
8 CD5 ϩ B lymphocytes, which are presumed to be more primitive cells, 24 seem to repopulate the periphery faster than CD5
Ϫ 'conventional' B lymphocytes following BMT. Although the median percentage of CD5 ϩ cells within the B lymphocyte population was high early after BMT, as described before, 25 the absolute counts of CD5 ϩ /CD20 ϩ B lymphocytes remained stable during the entire follow-up period. CD5
Ϫ B lymphocytes
Bone Marrow Transplantation increased only slowly, resembling normal ontogeny in the first year of life (E de Vries et al, Ped Research, in press). The absolute counts of T lymphocytes recovered more slowly: in only one third of the children levels above the p 5 were reached at 6 months after BMT. At that time, only two children (9%; both HLA-id) had reached levels above the p 5 for CD4 ϩ helper T lymphocytes, whereas 88% of the children had reached levels above the p 5 for CD8 ϩ suppressor/cytotoxic T lymphocytes. This very slow reconstitution of CD4 ϩ helper T lymphocytes was described before in adults, 5 but not in children. 15 However, Foot et al 15 did not apply age-matched reference values to evaluate the reconstitution of lymphocyte subpopulations in their study. The p 5 of the absolute counts of CD4 ϩ helper T lymphocytes is higher in younger children, resulting in an increasing threshold for 'recovery', with decreasing age. The comparatively slow recovery of CD4 ϩ helper T lymphocytes after BMT in children and adults is in contrast with the data of Mackall et al. 13 Their findings led to the conclusion that the thymus-dependent reconstitution of helper T lymphocytes after cytostatic therapy is delayed in adults in comparison with children. Maybe the pre-BMT conditioning regimen used in children with a haematological malignancy damages the thymus to such an extent that CD4 ϩ helper T lymphocyte development is impaired for a long period of time in paediatric bone marrow graft recipients as well. CD8 ϩ suppressor/cytotoxic T lymphocytes rapidly recovered to normal absolute counts after allogeneic BMT in the children, despite the potential damage to the thymus of the myelo-ablative therapy, but this was also described in adult BMT recipients 9 and after intensive chemotherapy. 13, 14 Unexpectedly, we found a clear positive influence of CMV-reactivation on quantitative CD4 ϩ helper T lymphocyte recovery. CMV represents a significant problem in the post-transplant period, with a high morbidity and mortality, especially in adults. 26 In healthy individuals, primary infection results in lymphocytosis of CD8 ϩ CTL during a mild or even subclinical illness. 27 These CTL are probably responsible for elimination of the active infection, and induction of protective immunity. A lymphocytosis of CD8 ϩ cytotoxic T lymphocytes was described in children after TCD ϩ BMT. 16 We also found a faster recovery of suppressor/cytotoxic T lymphocytes, assessed as total T lymphocyte minus CD4 ϩ helper T lymphocyte counts, in children with CMV-reactivation. The faster CD4
ϩ helper T lymphocyte recovery we found in children with CMVreactivation might be related to the more benign course of CMV-reactivation in children than in adults: Reusser et al 28 found a significant association between the presence of CMV-specific T helper cell proliferation and the development of CTL activity. However, we did not find a significant CMV-specific proliferation of T lymphocytes after BMT in the one child with CMV-reactivation we tested.
Our data confirm the findings by others 4,23 of a high percentage of 'memory' CD45RO ϩ helper T lymphocytes and a low percentage of 'naive' CD45RA ϩ helper T lymphocytes early post transplant. However, our data also show that a different picture emerges when absolute counts are considered. In fact, the 'memory' CD45RO ϩ helper T lymphocyte counts remain stable during a follow up period from 1 to 18 months after BMT, and the 'naive' CD45RA ϩ helper T lymphocyte counts increase slowly. Interestingly, the few T lymphocytes that were present at 1 month after BMT were also largely CD7 Ϫ , as was recently described in adults. 29 In normal individuals, a small subpopulation of CD7 Ϫ , mostly CD4 ϩ , CD45RO ϩ and CD45RA Ϫ primed 'memory' T lymphocytes exists, which is probably destined for homing to the skin. This subpopulation increases in size with age. 30 The absolute counts of CD7 ϩ T lymphocytes increased only slowly after BMT, whereas the absolute counts of CD7 Ϫ T lymphocytes remained stable during 18 months of follow-up.
In conclusion, we found that immune reconstitution after BMT, especially of CD4 ϩ helper T lymphocytes, is a slow process in children, as it is in adults. Unexpectedly, CD4 ϩ helper T lymphocyte recovery was significantly enhanced in children following CMV-reactivation. We did not find evidence of a peripheral expansion (ie increase of blood lymphocyte subpopulation absolute counts) of previously primed donor-derived CD45RO ϩ and CD7 Ϫ 'memory' T lymphocytes from 1 month after BMT onward in these children. Of course, it is possible that those lymphocytes that appear around 1 month after BMT are the result of such a peripheral expansion during the first month post transplant.
It is difficult to analyse this with immunophenotyping, due to the extremely low numbers of lymphocytes in the first month after BMT. As in adults, there was but a slow reconstitution of truly 'naive' CD45RA ϩ T lymphocytes emerging from the thymus.
